| 2026-03-06 | -29.7% | earnings | Seeking Alpha | Profound Medical outlines path to $85M revenue and profitable growth with TULSA expansion in 2026 |
| 2026-03-06 | -29.7% | earnings | Seeking Alpha | Profound Medical Corp. (PRN:CA) Q4 2025 Earnings Call Transcript |
| 2026-03-05 | -27.1% | earnings | Seeking Alpha | Profound Medical GAAP EPS of $0.27 beats by $0.55, revenue of $6M misses by $1.72M |
| 2026-03-05 | -27.1% | legal | SEC EDGAR | PROF 8-K: 2.02 and (SEC Filing) |
| 2026-03-05 | -27.1% | earnings | Yahoo Finance | Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance |
| 2026-03-05 | -27.1% | earnings | Benzinga | Profound Medical Q4 Earnings Assessment - Benzinga |
| 2026-03-05 | -27.1% | earnings | Investing.com Canada | Earnings call transcript: Profound Medical Q4 2025 EPS surprises, stock rises - Investing.com Canada |
| 2026-03-05 | -27.1% | earnings | Yahoo Finance | Profound Medical Q4 Earnings Call Highlights - Yahoo Finance |
| 2026-03-05 | -27.1% | news | Investing News Network | Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results - Investing News Network |
| 2026-03-05 | -27.1% | earnings | GuruFocus | Profound Medical (PROF) Reports Q4 Revenue Below Expectations - GuruFocus |
| 2025-09-23 | +25.7% | expansion | Seeking Alpha | Profound Medical rises as TULSA procedure launched at Dallas Medical Center |
| 2025-08-14 | -21.8% | earnings | Seeking Alpha | Profound Medical GAAP EPS of $0.52 beats by $0.92, revenue of $2.22M misses by $1.24M |
| 2025-08-14 | -21.8% | legal | SEC EDGAR | PROF 8-K: 2.02 and (SEC Filing) |
| 2025-05-09 | -17.2% | earnings | Seeking Alpha | Profound Medical GAAP EPS of $0.36, revenue of $2.6M |
| 2025-05-09 | -17.2% | expansion | Seeking Alpha | Profound Medical targets 70%-75% growth in 2025 with new TULSA AI module launch |
| 2025-05-09 | -17.2% | earnings | Seeking Alpha | Profound Medical Corporation (PROF) Q1 2025 Earnings Conference Call Transcript |
| 2025-10-07 | +16.4% | earnings | Seeking Alpha | Profound Medical achieves record prelim revenue for third quarter |
| 2025-10-07 | +16.4% | legal | SEC EDGAR | PROF 8-K: 2.02 and (SEC Filing) |
| 2025-10-07 | +16.4% | earnings | Investing News Network | Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter - Investing News Network |
| 2025-08-15 | -14.0% | earnings | Seeking Alpha | Profound Medical targets 70–75% revenue growth in 2025 as TULSA-AI and CAPTAIN trial progress fuel confidence |
| 2025-08-15 | -14.0% | earnings | Seeking Alpha | Profound Medical Corp. (PROF) Q2 2025 Earnings Call Transcript |
| 2025-08-15 | -14.0% | earnings | Yahoo Finance | Profound Medical Corp (PROF) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance |
| 2023-03-21 | -12.5% | news | Seeking Alpha | PROF stock cut to Hold at Jefferies on valuation (NASDAQ:PROF) - Seeking Alpha |
| 2026-03-26 | +9.8% | news | Zacks | Profound Medical (PROF) Surges 13.0%: Is This an Indication of Further Gains? |
| 2026-03-26 | +9.8% | news | Yahoo Finance | Profound Medical (PROF) Surges 13.0%: Is This an Indication of Further Gains? - Yahoo Finance |
| 2024-11-08 | -9.5% | earnings | Seeking Alpha | Profound Medical reports Q3 results |
| 2024-12-05 | -8.9% | news | Seeking Alpha | Profound Medical announces proposed public offering; shares fall |
| 2026-04-09 | -8.8% | news | GlobeNewswire | Profound Medical Corp. Investigated by the Portnoy Law Firm - GlobeNewswire |
| 2026-04-09 | -8.8% | news | Xã Vĩnh Công | Should I Buy Profound Medical (PROF) Stock Today | Price at $6.42, Down 1.08% - Attention Stocks - Xã Vĩnh Công |
| 2025-08-18 | +8.3% | news | Seeking Alpha | Profound Medical: Smoke Is Everywhere, Initiate At Sell |
| 2025-08-18 | +8.3% | news | Seeking Alpha | Profound Medical: Smoke Is Everywhere, Initiate At Sell (NASDAQ:PROF) - Seeking Alpha |
| 2025-12-19 | -7.9% | news | Seeking Alpha | Profound Medical announces pricing of up to $40 million financing |
| 2025-12-19 | -7.9% | legal | SEC EDGAR | PROF 8-K: 1.01, 8.01 (SEC Filing) |
| 2025-12-19 | -7.9% | news | MassDevice | Profound Medical prices $40M offering - MassDevice |
| 2025-12-19 | -7.9% | news | MSN | Profound Medical announces pricing of up to $40 million financing - MSN |
| 2025-11-11 | +7.7% | news | The Globe and Mail | Profound Medical Reclaims Canadian Distribution Rights for TULSA-PRO® - The Globe and Mail |
| 2025-11-11 | +7.7% | news | Investing.com | Profound Medical at Stifel 2025 Healthcare Conference: Strategic Growth Insights - Investing.com |
| 2026-01-15 | +7.7% | news | Stock Titan | AI-guided, incision-free prostate treatment debuts at Mount Sinai - Stock Titan |
| 2026-03-10 | +7.6% | legal | SEC EDGAR | PROF 8-K: 5.02 (SEC Filing) |
| 2025-11-13 | +7.5% | earnings | Seeking Alpha | Profound Medical GAAP EPS of $0.26 beats by $0.64, revenue of $5.03M misses by $0.04M |
| 2024-11-10 | -6.8% | earnings | Seeking Alpha | Profound Medical Corporation (PROF) Q3 2024 Earnings Call Transcript |
| 2025-03-07 | -5.4% | earnings | Seeking Alpha | Profound Medical Corporation (PROF) Q4 2024 Earnings Conference Call Transcript |
| 2025-03-07 | -5.4% | legal | SEC EDGAR | PROF 8-K: 1.01, 2.02, 2.03, 4.02 (SEC Filing) |
| 2026-03-20 | +5.3% | news | Benzinga | Top 3 Health Care Stocks That Are Set To Fly In March - BioMarin Pharmaceutical (NASDAQ:BMRN), Inspire Me - Benzinga |
| 2025-03-06 | -5.2% | earnings | Seeking Alpha | Profound Medical GAAP EPS of $0.20 beats by $0.52, revenue of $4.2M beats by $0.03M |
| 2025-12-31 | +5.1% | legal | SEC EDGAR | PROF 8-K: 1.01, 3.02, 7.01 (SEC Filing) |
| 2026-03-16 | +4.9% | analyst | Investing.com | Profound Medical stock rating reiterated by Raymond James on trial data - Investing.com |
| 2024-12-06 | -4.8% | news | Seeking Alpha | Profound Medical prices $35M public offering; shares down |
| 2024-12-06 | -4.8% | news | Seeking Alpha | Profound stock slides 6% on $35M public offering pricing |
| 2026-04-15 | +4.7% | news | UBND thành phố Hải Phòng | Profound Medical (PROF) Stock: Momentum Signals (Smart Money Active) 2026-04-15 - Social Momentum Signals - UBND thành phố Hải Phòng |
| 2026-04-15 | +4.7% | news | Cổng thông tin điện tử tỉnh Lào Cai | Profound Medical (PROF) Stock: Momentum Signals (Smart Money Active) 2026-04-15 - Community Sell Signals - Cổng thông tin điện tử tỉnh Lào Cai |
| 2026-04-15 | +4.7% | news | Cổng thông tin điện tử Tỉnh Sơn La | Galmed Pharmaceuticals (GLMD) Stock: Beginner's Guide (Smart Money Outflows) 2026-04-15 - Fast Moving Stocks - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-04-12 | +4.4% | news | Stock Traders Daily | Understanding the Setup: (PROF) and Scalable Risk - Stock Traders Daily |
| 2025-05-08 | -4.3% | earnings | Seeking Alpha | Profound Medical GAAP EPS of $0.36 beats by $0.64, revenue of $2.62M misses by $0.78M |
| 2025-05-08 | -4.3% | legal | SEC EDGAR | PROF 8-K: 2.02 and (SEC Filing) |
| 2026-04-21 | -4.0% | news | FinancialContent | INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF - FinancialContent |
| 2026-02-12 | +4.0% | news | Stock Titan | New prostate treatment earns Canadian tech its Mount Logan prize - Stock Titan |
| 2026-02-12 | +4.0% | news | Investing News Network | Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th - Conference Call to Follow - Investing News Network |
| 2026-04-10 | -3.6% | news | Cổng thông tin điện tử Tỉnh Sơn La | Is Profound Medical (PROF) Stock in a Selling Zone | Price at $6.24, Down 3.18% - Viral Trades - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-03-27 | -3.5% | news | GlobeNewswire | Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone |
| 2026-03-27 | -3.5% | news | Stock Titan | Dallas prostate center says Medicare shift lifted TULSA cases 500% - Stock Titan |
| 2025-03-12 | +3.4% | legal | Business Wire | Securities Fraud Investigation Into Profound Medical Corp. (PROF) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz - Business Wire |
| 2025-03-13 | -3.0% | legal | The AI Journal | Securities Fraud Investigation Into Profound Medical Corp. (PROF) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm - The AI Journal |
| 2026-04-13 | +3.0% | news | Xã Thanh Hà | What support levels matter for Sphere Entertainment (SPHR) Stock | Price at $128.38, Down 0.01% - Community Breakout Alerts - Xã Thanh Hà |
| 2026-02-01 | +3.0% | news | Yahoo! Finance Canada | Opinion: This Is the Only TSX Growth Stock to Own for the Next 3 Years - Yahoo! Finance Canada |
| 2025-09-25 | -2.9% | news | Seeking Alpha | Profound Medical: Expectations Worsen |
| 2025-09-25 | -2.9% | news | Seeking Alpha | Profound Medical: Expectations Worsen (NASDAQ:PROF) - Seeking Alpha |
| 2025-09-25 | -2.9% | earnings | RTTNews | Can Profound Medical Deliver Over 70% Revenue Growth In 2025? - RTTNews |
| 2025-11-14 | +2.7% | earnings | Seeking Alpha | Profound Medical Corp. (PRN:CA) Q3 2025 Earnings Call Transcript |
| 2021-07-18 | -2.6% | earnings | Zacks Investment Research | What date does Profound Medical's (PROF) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research |
| 2026-03-14 | +2.6% | news | TipRanks | Profound Medical reports CAPTAIN trial meets primary safety endpoint |
| 2021-09-15 | +2.5% | news | The Motley Fool | OraSure Technologies - OSUR - Stock Price & News - The Motley Fool |
| 2026-03-13 | +2.4% | news | MT Newswires | Profound Medical Reports Positive Trial Results for Tulsa Prostate Cancer Therapy |
| 2026-03-13 | +2.4% | news | GlobeNewswire | CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence |
| 2026-03-13 | +2.4% | news | Seeking Alpha | Profound Medical Corp. (PRN:CA) Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer Transcript |
| 2026-03-13 | +2.4% | news | Stock Titan | Prostate trial: MRI-guided TULSA helps more men keep sex and bladder control - Stock Titan |
| 2024-01-04 | -2.4% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2021-10-02 | -2.4% | news | Cantech Letter | Profound Medical is a Strong Buy, says Raymond James - Cantech Letter |
| 2026-04-16 | +2.1% | news | GlobeNewswire | Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow |
| 2026-04-16 | +2.1% | earnings | Stock Titan | Profound Medical schedules May 7 earnings call after market close - Stock Titan |
| 2026-04-16 | +2.1% | earnings | Stock Titan | Profound Medical (NASDAQ: PROF) to report Q1 2026 results, host call May 7 - Stock Titan |
| 2025-04-30 | -2.0% | news | Seeking Alpha | Profound Medical: In Serious Trouble Despite Projected Growth |
| 2025-04-30 | -2.0% | news | Seeking Alpha | Profound Medical: In Serious Trouble Despite Projected Growth (NASDAQ:PROF) - Seeking Alpha |
| 2022-12-31 | +1.9% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Profound Medical (PROF) - Zacks Investment Research |
| 2026-01-20 | -1.8% | news | Yahoo Finance | Investors in Profound Medical (TSE:PRN) have unfortunately lost 67% over the last five years - Yahoo Finance |
| 2025-06-25 | -1.6% | news | Yahoo Finance | Profound Medical Completes First Commercial BPH Treatment With New TULSA-AI Volume Reduction Module - Yahoo Finance |
| 2026-04-01 | -1.6% | news | GlobeNewswire | Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting |
| 2026-04-01 | -1.6% | news | Stock Titan | TULSA-PRO showcased at SIR 2026 for Profound Medical (NASDAQ: PROF) - Stock Titan |
| 2026-04-01 | -1.6% | news | Stock Titan | Incision-free prostate treatment lands 7 talks at April medical meeting - Stock Titan |
| 2026-04-01 | -1.6% | news | Cổng thông tin điện tử tỉnh Lào Cai | ZBH Stock Analysis: Zimmer Biomet Holdings Inc Up 0.67 Pct Near 91 Dollar Mark - Cổng thông tin điện tử tỉnh Lào Cai |
| 2026-04-01 | -1.6% | news | Minichart | Profound Medical’s TULSA-PRO® Incision-Free, MRI-Guided Prostate Treatment Highlighted at 2026 Society of Interventional Radiology Meeting - Minichart |
| 2025-04-22 | -1.3% | legal | SEC EDGAR | PROF 8-K: 8.01 and (SEC Filing) |
| 2026-04-06 | -1.3% | earnings | Cổng thông tin điện tử Tỉnh Sơn La | Will Profound Medical (PROF) Stock Beat Expectations | Price at $6.85, Up 6.53% - Real Trader Network - Cổng thông tin điện tử Tỉnh Sơn La |
| 2025-04-24 | -1.2% | news | Stock Titan | RCEL Stock Price, News & Analysis - Stock Titan |
| 2025-04-24 | -1.2% | news | Stock Titan | RPID Stock Price, News & Analysis - Stock Titan |
| 2025-04-24 | -1.2% | news | Stock Titan | HYPR Stock Price, News & Analysis - Stock Titan |
| 2025-04-24 | -1.2% | news | Stock Titan | OWLT Stock Price, News & Analysis - Stock Titan |
| 2026-03-09 | +1.2% | news | GlobeNewswire | Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24 |
| 2026-03-09 | +1.2% | news | Streetwise Reports | Medical Co.'s TULSA-PRO Installed Base Growth & CAPTAIN Trial Data Could Accelerate Adoption in 2026 - Streetwise Reports |
| 2026-04-23 | +1.1% | news | Stock Traders Daily | Responsive Playbooks and the PROF Inflection - Stock Traders Daily |
| 2026-04-23 | +1.1% | analyst | MSN | Profound Medical (PROF) price target decreased by 26.77% to 8.49 - MSN |
| 2026-04-23 | +1.1% | earnings | soytecaobang.gov.vn | UWMC (UWM Holdings Corporation) slips 1.57% after Q4 2025 EPS misses analyst estimates by 9.3 percent. - Momentum Score - soytecaobang.gov.vn |
| 2025-12-24 | -0.7% | news | Seeking Alpha | Profound Medical increases private placement to $6.45M |
| 2022-08-24 | -0.7% | news | The Motley Fool Canada | Profound Medical Corp. (TSX:PRN) Stock Price & News - The Motley Fool Canada |
| 2025-05-07 | -0.7% | earnings | Yahoo Finance | Profound Medical Corp (TSX:PRN) Q1 2025 Earnings Report Preview: What To Look For - Yahoo Finance |
| 2025-11-12 | +0.4% | M&A | Seeking Alpha | Profound Medical inks exclusive Saudi deal for TULSA-PRO and Sonalleve, stock rises |
| 2025-11-12 | +0.4% | earnings | Yahoo Finance | Profound Medical Corp (PROF) Q3 2025 Earnings Report Preview: What To Look For - Yahoo Finance |
| 2026-04-14 | +0.4% | news | GlobeNewswire | Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference |
| 2026-04-14 | +0.4% | news | Stock Titan | Profound Medical to give business update at Toronto investor event - Stock Titan |
| 2026-04-14 | +0.4% | news | Stock Titan | Profound Medical (NASDAQ: PROF) plans business update at 2026 Bloom Burton healthcare investor conference - Stock Titan |
| 2026-04-14 | +0.4% | news | marketscreener.com | Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference - marketscreener.com |
| 2025-06-05 | +0.4% | news | Intellectia AI | PROF Forecast — Price Prediction for 2026. Should I Buy PROF? - Intellectia AI |
| 2022-01-18 | +0.3% | news | Yahoo Finance | Bullish Profound Medical Corp. (TSE:PRN) insiders filled their treasuries with US$782k worth of stock over last year - Yahoo Finance |
| 2025-04-25 | -0.3% | news | Stock Titan | PROF Stock Price, News & Analysis - Stock Titan |
| 2025-01-08 | +0.2% | earnings | Seeking Alpha | Profound Medical reports FY24 revenue above consensus |
| 2025-01-08 | +0.2% | legal | SEC EDGAR | PROF 8-K: 2.02 and 8.01 (SEC Filing) |
| 2025-01-08 | +0.2% | earnings | Stock Titan | Profound Medical Reports Record Q4: Revenue Doubles Year-Over-Year to $4.2M - Stock Titan |
| 2026-04-25 | — | analyst | MarketBeat | Profound Medical Showcases TULSA Data, AI Software Upgrades, and Reimbursement Tailwinds at Conference |